How digitalization helps companies overcome manufacturing challenges

Featured image - people working in office
Share Article
Mégane Noirfalise
18/03/2022

Digital transformation has been spreading throughout industries and pharmaceutical companies are no exception. The development of the recent COVID-19 vaccine is a good exemple of the impact and benefits that digitalization can have on reducing clinical development timelines.

SCO-G

Sébastien Coppe, Life Sciences Director at N-SIDE, discusses how digitalization positively impacts pharmaceutical companies to overcome manufacturing challenges in the Pharmaceutical Manufacturing and Packing Source Magazine.

In this article, Sébastien outlines the obstacles pharma R&D manufacturing often faces and how digital and analytical solutions deliver a clear added value for an organization.

Analytical platforms allow both an increased visibility in the global clinical plan and an increased efficiency to execute this plan.” - Sébastien Coppe, N-SIDE

Among many other advantages, digitalization not only benefits companies but it also has a positive impact for patients and society at large. With the right tools, manufacturing bottlenecks can be identified and ultimately removed to ensure faster clinical developments timelines.

In this article, you will also discover:

  • How a digital solution lead to millions of budget reductions and considerable waste avoidance
  • Must-have technologies to optimize the pharma R&D manufacturing and how to implement them

If you are interested to know more about the challenges of digitalization in pharma manufacturing and how companies can use these technologies to optimize their strategy, you can read Sébastien’s full interview here.

Read article

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer October 2021, pages 93-95. © Samedan Ltd

 

About the Author

Life Sciences Marketing Coordinator

Mégane Noirfalise

Do you want to know more?

Request Demo or Info